Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Factors influencing survival of children with nonmetastatic neuroblastoma.
Evans AE, Albo V, D'Angio GJ, Finklestein JZ, Leiken S, Santulli T, Weiner J, Hammond GD. Evans AE, et al. Among authors: albo v. Cancer. 1976 Aug;38(2):661-6. doi: 10.1002/1097-0142(197608)38:2<661::aid-cncr2820380206>;2-m. Cancer. 1976. PMID: 788890 Clinical Trial.
Dibromodulcitol (NSC-104800) compared with cyclophosphamide (NSC-26271) as remission maintenance therapy in previously treated children with acute lymphoblastic leukemia or acute undifferentiated leukemia: possible effectiveness in reducing the incidence of central nervous system leukemia.
Sitarz AL, Albo V, Movassaghi N, Karon M, Hammond D, Weiner J, Reed A. Sitarz AL, et al. Among authors: albo v. Cancer Chemother Rep. 1975 Sep-Oct;59(5):989-94. Cancer Chemother Rep. 1975. PMID: 1106848 Clinical Trial.
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group.
Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, Grossman NJ, Littman PS, Novak LT, Pyesmany AF, et al. Gaynon PS, et al. Among authors: albo vc. Lancet. 1988 Oct 22;2(8617):921-4. doi: 10.1016/s0140-6736(88)92596-2. Lancet. 1988. PMID: 2902379 Clinical Trial.
29 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page